Influenza a outbreak in an ambulatory stem cell transplant center

Open Forum Infectious Diseases

Volumn 1, Issue 2, 2014, Pages

  Apewokin, Senu ^a   Vyas, Keyur ^b   Lester, Laura K ^c,d   Grazzuitti, Monica ^a   Haselow, Dirk T ^d   Wolfe, Frankie ^a   Roberts, Michelle ^a   Bellamy, William ^a   Kumar, Naveen Sanath ^a   Hunter, Dolris ^a   Lee, Jeannette ^a   Laudadio, Jennifer ^a   Wheeler, J Gary ^d   Bradsher, Robert ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d ARKANSAS DEPARTMENT OF HEALTH   (United States)

Author keywords

Ambulatory; C reactive protein; Hematopoietic stem cell transplantation; Influenza A; Vaccination

Indexed keywords

C REACTIVE PROTEIN; INFLUENZA VACCINE; OSELTAMIVIR;

ACUTE MYELOBLASTIC LEUKEMIA; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; COUGHING; DEMOGRAPHY; FEMALE; FEVER; HEALTH CENTER; HUMAN; INFECTION CONTROL; INFLUENZA A; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUTROPENIA; NEUTROPHIL COUNT; NOSE SMEAR; OXYGEN SATURATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SORE THROAT; STEM CELL TRANSPLANTATION;

EID: 84978328042     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu050     Document Type: Article

References (17)

1. Wong BC, Lee N, Li Y, et al. Possible role of aerosol transmission in a hospital outbreak of influenza. Clin Infect Dis 2010; 51:1176-83.
2. Barlogie B, Anaissie E, van Rhee F, et al. The Arkansas approach to therapy of patients with multiple myeloma. Best Pract Res Clin Haematol 2007; 20:761-81.
3. Barlogie B, Jagannath S, Desikan KR, et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999; 93:55-65.
4. Barlogie B, Tricot G, Rasmussen E, et al. Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies. Blood 2006; 107:2633-8.
5. Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant 2008; 42:637-41.
6. Ruben LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immuncompromised host. Clin Infect Dis 2014; 58:e44-100.
7. Yri OE, Torfoss D, Hungnes O, et al. Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood 2011; 118:6769-71.
8. Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994; 83:435-45.
9. Robertson JD, Nagesh K, Jowitt SN, et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000; 82:1261-5.
10. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant 2009; 44:453-5.
11. Ison MG, Szakaly P, Shapira MY, et al. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients. Antivir Ther 2012; 17:955-64.
12. Kruger WH, Hornung RJ, Hertenstein B, et al. Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res 2001; 10:895-903.
13. Hicheri Y, Einsele H, Martino R, et al. Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Transpl Infect Dis 2013; 15: 251-8.
14. Roux E, Dumont-Girard F, Starobinski M, et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000; 96:2299-303.
15. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 2007; 110:1681-8.
16. Centers for Disease Control and Prevention. Overview of influenza surveillance in the United States. Available at: http://www.cdc.gov/flu/ weekly/pdf/overview.pdf. Accessed 15 December 2013.
17. Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2002; 2:175-87.